Conference Call to be Held at 4:30pm Eastern Time

东部时间下午4:30召开电话会议

ROCKAWAY, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the fourth quarter and year ended December 31, 2020 after the close of the market on Thursday, March 11, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

2013年3月11日讯/生物谷bioon /——电芯公司(Nasdaq: ECOR)宣布，将在2021年3月11日周四股市收盘后，公布截至2020年12月31日的第四季度和年度财务业绩。管理层将在东部时间下午4:30举行电话会议和网络直播，讨论财务结果并回答问题。

About electroCore, Inc.

关于electroCore公司。

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.

electroCore, Inc.是一家商业阶段的生物电子医药公司，致力于通过其平台非侵入性迷走神经刺激疗法改善患者的预后，最初专注于神经病学的多种病症的治疗。该公司目前的适应症是辅助应用于成人患者丛集性头痛的预防性治疗，成人患者丛集性头痛相关疼痛的急性治疗，以及青少年(12岁及以上)和成人患者偏头痛的急性和预防性治疗。